Particular emphasis will be placed on developing scientifically rigorous study protocols, defining clinically meaningful endpoints and target populations, evaluating potential sources of bias and confounding, and ensuring that study designs generate credible evidence to support regulatory, clinical, reimbursement, and commercial decision-making. This individual serves as a clinical epidemiology and observational research expert, partnering with Clinical, Regulatory, R&D, Medical Affairs, Marketing, HEMA, HEOR, and divisional stakeholders to translate important clinical and business questions into scientifically rigorous real-world evidence programs.